Divorce among physicians and other healthcare professionals in the US

BMJ ◽  
2015 ◽  
pp. h2106
Author(s):  
Neil Chanchlani ◽  
James Goodhand
Keyword(s):  
Healthcare Professionals ◽  
The Us

scholarly journals Sex in Late Life: Assessing Adults’ Expectations and the Role of Healthcare Professionals

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 313-313
Author(s):  
Jill Naar ◽  
Raven Weaver ◽  
Shelbie Turner
Keyword(s):  
Older Adults ◽  
Sexual Health ◽  
Health Behaviors ◽  
Healthcare Professionals ◽  
Late Life ◽  
Sexual History ◽  
Growth Curve Models ◽  
The Us ◽  
Sexual Health Behaviors ◽  
The Life Course

Abstract Sexual activity contributes to quality of life throughout the lifespan. However, stigma about sex in late life influences older adults’ perceptions and healthcare professionals’ perceptions of older adults’ sexual health/behaviors. Using a multi-methods approach, we examined attitudes and knowledge about sexual health/behaviors in late life. Using longitudinal data from the Midlife in the US Study (Wave 1-3; N=7049), we ran age-based growth curve models to analyze changes in levels of optimism about sex in their future. We also piloted a survey with healthcare professionals assessing attitudes, knowledge, and awareness of policy about sexual health/behaviors among older adults. Adults’ expectations became less optimistic with increased age (β = -0.1, SE = 0.003, p < .0001). Men were more optimistic than women at age 20 (p = 0.016), but men’s optimism decreased over the life course at a faster rate than did women’s (p < .0001), so that from ages 40-93, men were less optimistic than women. Among healthcare professionals (N=21), the majority indicated never or rarely asking their clients about sexual history or health/behaviors; however, they indicated some knowledge about issues relevant to older adults (e.g., safe-sex practices, sexual dysfunction). Few indicated awareness about policies related to sexual behavior among residents (i.e., issues of consent, STIs). Among adults, there is a need to address declining optimism for expectations about sex in late life. Health professionals are well-situated to raise awareness and normalize discussions about sexual health, thus countering negative stigma and contributing to increasing optimism for expectations to remain sexually active.

scholarly journals Multiple Sclerosis: Overview of Disease-Modifying Agents

2014 ◽  
Vol 6 ◽  
pp. PMC.S13213 ◽  
Author(s):  
Alessandro Finkelsztejn
Keyword(s):  
Multiple Sclerosis ◽  
Healthcare Professionals ◽  
Drug Class ◽  
Cognitive Disability ◽  
Oral Drugs ◽  
The Us ◽  
Disease Modifying Agents ◽  
Phase Ii And Iii ◽  
Chronic Autoimmune Disease

Multiple sclerosis (MS) is a chronic autoimmune disease that usually affects young adults, causing progressive physical and cognitive disability. Since the 1990s, its treatment has been based on parenteral medications known collectively as immunomodulators. This drug class is considered safe and usually prevents 30% of MS relapses. Drugs in this class exert almost the same efficacy and require an inconvenient administration route. New medications have recently been launched worldwide. Thus, new oral drugs are increasingly being administered to MS patients and contributing to a better quality of life, since these have better efficacy than the old immunomodulators. Today, 10 different drugs for MS are marketed worldwide, which requires deep knowledge among neurologists and other healthcare professionals. This paper summarizes all the drugs approved for MS in the US and Europe, emphasizing their mechanism of action, the results from phase II and III studies, and the product safety.

scholarly journals Prevalence of Stress in Healthcare Professional During COVID-19 Pandemic in Northeast México: A Remote Fast Survey Evaluation, the Use of an Adapted COVID-19 Stress Scale

2020 ◽  
Author(s):  
Juan Luis Delgado-Gallegos ◽  
Rene de Jesus Montemayor-Garza ◽  
Gerardo R. Padilla-Rivas ◽  
Hector Franco-Villareal ◽  
Jose Francisco Islas
Keyword(s):  
Traumatic Stress ◽  
Healthcare Professionals ◽  
Well Being ◽  
Health Crisis ◽  
Stress Scale ◽  
Work Area ◽  
The Us ◽  
Compulsive Checking ◽  
Novel Coronavirus ◽  
Survey Evaluation

The world is currently, subjected to the worst health crisis documented in modern history; an epidemic led by the novel coronavirus disease 2019 (COVID-19). At the epicenter of this crisis, healthcare professionals continue working to safeguard our well-being. To the regular high levels of stress, COVID new heights even more to healthcare professionals so depending on the area, specialty, and type of work. Here we investigated what are the tendencies, or areas most affected. Through an adaptation of the original COVID-stress scale, we developed a remote, fast test designed for healthcare professionals of the Northeastern part of Mexico, an important part of the country with economic and cultural ties to the US. Our results showed 4 key correlations as highly dependent: Work area – Xenophobia (p < 0.045), Work with COVID patients - Traumatic stress (p < 0.001) and Total number of COVID patients per day – Traumatic stress (p < 0.027), and Total number of COVID patients - Compulsive checking and reassurance. Overall concluding that normal levels of stress have increased (mild – moderate). Additionally, we further determine that the fear of being an asymptomatic patient (potential to spread without knowing) continues being a concern.

scholarly journals Gluten in pharmaceutical products: a scoping review

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Irene Lizano-Díez ◽  
Eduardo L. Mariño ◽  
Pilar Modamio
Keyword(s):  
Scoping Review ◽  
Healthcare Professionals ◽  
Pharmaceutical Products ◽  
Current Evidence ◽  
Gluten Free ◽  
Scoping Reviews ◽  
The Us ◽  
Wide Variability ◽  
Definition Of

Abstract Background Celiac disease (CD) is one of the most common gluten-related disorders. Although the only effective treatment is a strict gluten-free diet, doubts remain as to whether healthcare professionals take this restriction into consideration when prescribing and dispensing medicines to susceptible patients. This scoping review aimed to find out the current evidence for initiatives that either describe the gluten content of medicines or intend to raise awareness about the risk of prescribing and dispensing gluten-containing medicines in patients with CD and other gluten-related disorders. Methods A scoping review was conducted using three search strategies in PubMed/MEDLINE, TripDatabase and Web of Science in April 2021, following the PRISMA extension for scoping reviews (PRISMA-ScR). References from included articles were also examined. Two researchers screened the articles and results were classified according to their main characteristics and outcomes, which were grouped according to the PCC (Population, Concept and Context) framework. The initiatives described were classified into three targeted processes related to gluten-containing medicines: prescription, dispensation and both prescription and dispensation. Results We identified a total of 3146 records. After the elimination of duplicates, 3062 articles remained and ultimately 13 full texts were included in the narrative synthesis. Most studies were conducted in the US, followed by Canada and Australia, which each published one article. Most strategies were focused on increasing health professional’s knowledge of gluten-containing/gluten-free medications (n = 8), which were basically based on database development from manufacturer data. A wide variability between countries on provided information and labelling of gluten-containing medicines was found. Conclusion Initiatives regarding the presence of gluten in medicines, including, among others, support for prescribers, the definition of the role of pharmacists, and patients’ adherence problems due to incomplete labelling of the medicines, have been continuously developed and adapted to the different needs of patients. However, information is still scarce, and some aspects have not yet been considered, such as effectiveness for the practical use of solutions to support healthcare professionals.

scholarly journals Highlights of thoracic oncology from the 2018 ERS International Congress

2019 ◽  
Vol 5 (2) ◽  
pp. 00222-2018
Author(s):  
Polyxeni Ntontsi ◽  
Clementine Bostantzoglou ◽  
Torsten Gerriet Blum
Keyword(s):  
Lung Cancer ◽  
Healthcare Professionals ◽  
Lung Cancer Screening ◽  
American Thoracic Society ◽  
International Congress ◽  
European Respiratory Society ◽  
National Initiatives ◽  
The Us ◽  
American Lung Association ◽  
Related Mortality

Lung cancer is a substantial global burden for patients, healthcare professionals and healthcare systems. Multiple scientific international and national initiatives are tackling the various problems associated with this disease, which is currently the leading cause of cancer-related mortality worldwide. During the European Respiratory Society International Congress 2018 in Paris, France, lung cancer experts gathered to present the most recent aspects of lung cancer care, and discuss the need for joint initiatives and an international lung cancer alliance, aiming to provide high quality, accessible health care. The US experience and American Lung Association/American Thoracic Society implementation guide on lung cancer screening programmes, the key features of optimising and implementing such programmes, the challenges of treatment in the subset of patients where lung cancer is combined with interstitial lung disease, and novel lung cancer biomarkers and immunotherapy were among the most anticipated issues covered during the congress.

Reintegrating droperidol into emergency medicine practice

2020 ◽  
Vol 77 (22) ◽  
pp. 1838-1845
Author(s):  
Alicia Mattson ◽  
Kimberly Friend ◽  
Caitlin S Brown ◽  
Daniel Cabrera
Keyword(s):  
Clinical Efficacy ◽  
Healthcare Professionals ◽  
The United States ◽  
Boxed Warning ◽  
Interval Prolongation ◽  
Efficacy Data ◽  
Qt Interval Prolongation ◽  
The Us ◽  
Acute Agitation ◽  
Effective Use

Abstract Purpose After a long period of low utilization, droperidol has become easier to obtain in the US market. This comprehensive review discusses the safety, indications, clinical efficacy, and dosing of droperidol for use in the emergency department (ED) setting. Summary In 2001 the US Food and Drug Administration (FDA) mandated a boxed warning in the labeling of droperidol after reports of QT interval prolongation associated with droperidol use. Since that time, it has been difficult to access droperidol in the United States; as a result, many practicing clinicians lack experience in its clinical use. Multiple studies have been conducted to assess the clinical efficacy and safety of droperidol use in ED patients. Results consistently show the safety of droperidol and its clinical efficacy when used as an analgesic, antiemetic, and sedative. Now that droperidol is more widely available for use in the US market, pharmacists and prescribers need to reliably translate safety and efficacy data compiled since 2001 to help ensure appropriate and effective use of the medication. Conclusion Droperidol is an effective and safe option for the treatment of acute agitation, migraine, nausea, and pain for patients in the ED setting. Healthcare professionals can adopt droperidol for use in clinical practice, and they should become familiar with how to dose and monitor droperidol for safe and effective use.

Internet Resources for Dentistry: Government and Medical Sites for the Dental Professional

1999 ◽  
Vol 1 (2) ◽  
pp. 12-19 ◽  
Author(s):  
Gary F. Guest
Keyword(s):  
Professional Growth ◽  
Global Economy ◽  
Healthcare Professionals ◽  
The Internet ◽  
Business Operations ◽  
Internet Resources ◽  
The Us ◽  
Us Government ◽  
Health Related ◽  
Dental Professional

Abstract As society transitions deeper into the Information Age, Information Technology has become a critical tool that supports all facets of the global economy. The Internet, via the World-Wide Web (WWW), has become a major component of business operations for corporate and educational organizational entities. An estimated 10,000 or more health-related websites are providing information for both consumers and healthcare professionals. In addition to private and state-supported institutions being present on the Internet, the federal government has moved rapidly toward disseminating information electronically, with significant utilization of the WWW as the technological vehicle. All branches of the US Government and federal-related agencies are now represented on the Internet in an effort to deliver content to their end users, primarily the public. The intent of this article is to complement the previous publication, “Internet Resources for Dentistry: Utilization of the Internet to Support Professional Growth, Decision Making, and Patient Care,” by presenting dental healthcare professionals with information on additional governmental and medical “Internet” sites. In addition, healthcare professionals must arm themselves with more than just access itself, but also the ability to critically judge the quality of information retrieved from the WWW.1,2,5

Sign in / Sign up

Export Citation Format

Share Document